1. Home
  2. CLDX vs TIC Comparison

CLDX vs TIC Comparison

Compare CLDX & TIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celldex Therapeutics Inc.

CLDX

Celldex Therapeutics Inc.

HOLD

Current Price

$25.87

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

TIC

Acuren Corporation

HOLD

Current Price

$10.38

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLDX
TIC
Founded
N/A
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
CLDX
TIC
Price
$25.87
$10.38
Analyst Decision
Buy
Buy
Analyst Count
10
3
Target Price
$44.10
$14.17
AVG Volume (30 Days)
718.4K
2.5M
Earning Date
11-10-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,599,000.00
$1,284,070,000.00
Revenue This Year
N/A
$41.97
Revenue Next Year
$19.70
$42.94
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.15
52 Week Low
$14.40
$8.76
52 Week High
$30.50
$14.94

Technical Indicators

Market Signals
Indicator
CLDX
TIC
Relative Strength Index (RSI) 44.96 50.99
Support Level $24.97 $10.12
Resistance Level $28.79 $10.59
Average True Range (ATR) 1.36 0.44
MACD -0.36 0.15
Stochastic Oscillator 16.46 49.66

Price Performance

Historical Comparison
CLDX
TIC

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About TIC Acuren Corporation

TIC Solutions Inc is a provider of tech-enabled Testing, Inspection, Certification and Compliance (TICC), engineering, and geospatial services. It provides mission-critical services that are essential to the safety, reliability, and efficiency of industrial assets, buildings and public infrastructure. The company's services are often non-discretionary and are driven by regulatory requirements, customer risk management policies, and the need to extend the useful life of critical assets. It operates in North America and serve both public- and private-sector clients. Its public-sector clients include federal, state, and municipal agencies, public utilities, and environmental regulators. Its private-sector clients span industrial, infrastructure, construction, and real estate end markets.

Share on Social Networks: